NCT00864916 Pentoxifylline and Combination Antiretroviral Therapy to Improve Blood Vessel Function in HIV-Infected People Status COMPLETED Phase PHASE2
NCT00859144 Training Community Members to Deliver HIV Prevention Programs to Urban Youth Status COMPLETED Phase PHASE3
NCT00858923 Safety Study of the HemoModulator System for the Treatment of Patients With Human Immunodeficiency Virus (HIV) Status UNKNOWN Phase PHASE1
NCT00856323 Contingency Management for Methamphetamine Abstinence and HIV Post-Exposure Prophylaxis in Men Who Have Sex With Men Status COMPLETED Phase PHASE2
NCT00855335 A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women Status COMPLETED Phase PHASE3
NCT00851630 Tuberculosis and Human Immunodeficiency Virus (HIV) Immune Reconstitution Syndrome Trial (THIRST) Status COMPLETED Phase PHASE4
NCT00851383 A Trial to Evaluate Ad35-GRIN/ENV HIV Vaccine in Healthy Adult Volunteers Status COMPLETED Phase PHASE1
NCT00850616 Three-Dose Regimen of MRKAd5+6 Trigene (V526) in Healthy Adults (V526-001)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00843661 Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients Status UNKNOWN Phase PHASE4
NCT00842634 Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV Status COMPLETED Phase PHASE1
NCT00840905 A Study to Examine the Human Papillomavirus Types Exposure in Women From Southern Africa and Brasil Status COMPLETED Phase N/A
NCT00840658 Behavioral Intervention to Reduce Sexual and Injection Risks Among Female Sex Workers Who Also Inject Drugs in Mexico Status COMPLETED Phase PHASE2
NCT00838292 Study of Impacts of Food Supplementation on Malnourished HIV-Infected Adults in Kenya Status COMPLETED Phase NA
NCT00830622 Cell Phone Intervention to Support Antiretroviral Therapy (ART) Adherence in Kenya Status COMPLETED Phase NA
NCT00828815 TMC125-TiDP2-C188: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Effect of Multiple-dose TMC125 on Buprenorphine and Norbuprenorphine Administered in HIV-negative Patients on Stable Buprenorphine/Naloxone Maintenance Therapy. Status COMPLETED Phase PHASE1